Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E De La Morena

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Annals of the New York Academy of Sciences|January 1, 1991
Efficacy of CDP-choline in the treatment of senile alterations in memoryE de la Morena
Clinical Biochemistry|December 1, 1979
2,3-Diphosphoglycerate, a cellular ageing metaboliteE de la Morena
Acta Biologica Et Medica Germanica|January 1, 1977
Increased susceptibility of carbamylated glutamate dehydrogenase to proteolysisW Hood, E de la Morena, S Grisolia
Clinical Therapeutics|January 1, 1988
Levo-carnitine, its derivatives, and free fatty acids in serum, heart, liver, and muscle of both tumoral and alcoholic ratsE De la Morena, E J Berlanas, C Gomez
Polish Archives of Internal Medicine|May 20, 2020
Antithrombin deficiency as a still underdiagnosed thrombophilia: a primer for internistsCarlos Bravo-Pérez, Maria E de la Morena-Barrio, Vicente Vicente, et al.
Journal of Hepatology|November 1, 1994
Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the LiverA Escorsell, A Parés, J Rodés, et al.
Hepatology (Baltimore, Md.)|November 1, 1981
Morphometric study of the esophageal mucosa in cirrhotic patients with variceal bleedingJ Ponce, A Froufe, E de la Morena, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 17, 2008
Clinical case report and literature review: metachronous colorectal splenic metastasesJ M Gasent Blesa, E de la Morena, J B Laforga Canales, et al.
Gut|February 1, 1992
Functional impairment of natural killer cells in active ulcerative colitis: reversion of the defective natural killer activity by interleukin 2L Manzano, M Alvarez-Mon, L Abreu, et al.
Gastroenterologia Y Hepatologia|July 19, 2001
[Abdominal actinomycosis simulating Crohn's disease]F Sevilla Chica, F Villalba Ferrer, C Domingo Del Pozo, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Annals of the New York Academy of Sciences|January 1, 1991
Efficacy of CDP-choline in the treatment of senile alterations in memoryE de la Morena
Clinical Biochemistry|December 1, 1979
2,3-Diphosphoglycerate, a cellular ageing metaboliteE de la Morena
Acta Biologica Et Medica Germanica|January 1, 1977
Increased susceptibility of carbamylated glutamate dehydrogenase to proteolysisW Hood, E de la Morena, S Grisolia
Clinical Therapeutics|January 1, 1988
Levo-carnitine, its derivatives, and free fatty acids in serum, heart, liver, and muscle of both tumoral and alcoholic ratsE De la Morena, E J Berlanas, C Gomez
Polish Archives of Internal Medicine|May 20, 2020
Antithrombin deficiency as a still underdiagnosed thrombophilia: a primer for internistsCarlos Bravo-Pérez, Maria E de la Morena-Barrio, Vicente Vicente, et al.
Journal of Hepatology|November 1, 1994
Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the LiverA Escorsell, A Parés, J Rodés, et al.
Hepatology (Baltimore, Md.)|November 1, 1981
Morphometric study of the esophageal mucosa in cirrhotic patients with variceal bleedingJ Ponce, A Froufe, E de la Morena, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 17, 2008
Clinical case report and literature review: metachronous colorectal splenic metastasesJ M Gasent Blesa, E de la Morena, J B Laforga Canales, et al.
Gut|February 1, 1992
Functional impairment of natural killer cells in active ulcerative colitis: reversion of the defective natural killer activity by interleukin 2L Manzano, M Alvarez-Mon, L Abreu, et al.
Gastroenterologia Y Hepatologia|July 19, 2001
[Abdominal actinomycosis simulating Crohn's disease]F Sevilla Chica, F Villalba Ferrer, C Domingo Del Pozo, et al.
Pageof 4